7 completed, 2 terminated. 3 Phase 2, 2 Not applicable, 2 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Not applicable | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow Gestodene: new trials by email Literature Review of Gestodene trials Research Report on Gestodene
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "Quick-starting" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition Quadriphasic Estradiol valerate 1 - 3 mg/ Dienogest 2 - 3 mg (26/2), Ethinylestradiol (EE) 20 mcg/Gestodene 75 mcg (21/7) - Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus | Not applicable | Completed | Chulalongkorn University | 40 | 2024-05-09 | 2026-08-25 |
| "Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition Estetrol 15 mg/Drospirenone 3 mg (24/4), Ethinylestradiol (EE) 20 mcg/Gestodene 75 mcg (21/7) - Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus | Not applicable | Completed | Chulalongkorn University | 36 | 2024-05-01 | 2025-05-20 |
| Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT 1.5 mg estradiol and 2.5 mg nomegestrol acetate, 15 µg ethinylestradiol and 60 µg gestodene - Contraception, Hypercoagulability | Phase 4 | Terminated | Mahidol University | 112 | 2016-03-01 | 2018-05-21 |
| Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD) Ethinylestradiol/Gestodene (BAY86-5016) - Contraception, Ovulation Inhibition | Phase 2 | Completed | Bayer | 108 | 2009-06-01 | 2014-10-28 |
| Birth Control Patch Study Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016), Norelgestromin/Ethinylestradiol (EVRA) - Contraception | Phase 3 | Completed | Bayer | 393 | 2009-05-01 | 2014-04-02 |
| US Ovulation Inhibition Study in Obese Women Ethinylestradiol/Gestodene (BAY86-5016) - Contraception | Phase 2 | Completed | Bayer | 173 | 2009-04-30 | 2021-04-08 |
| EU/LA Pearl Index Study - Transdermal Contraceptive Patch Ethinylestradiol/Gestodene (BAY86-5016) - Contraception | Phase 3 | Completed | Bayer | 1694 | 2009-04-01 | 2014-12-05 |
| Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene Ethinylestradiol/Gestodene (BAY86-5016) - Contraception, Ovulation Inhibition | Phase 2 | Terminated | Bayer | 17 | 2008-08-01 | 2014-12-02 |
| Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme gestoden 60 mcg, ethinylestradiol 15 mcg - Quality of Life, Menopause | Phase 4 | Completed | Hospital Geral de Fortaleza | 100 | 2008-01-01 | 2010-08-03 |
Hemorrhage (1) · Thrombophilia (1)
Bayer (5) · Chulalongkorn University (2) · Hospital Geral de Fortaleza (1) · Mahidol University (1)
Germany (3) · Thailand (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Chile (1) · Czechia (1) · France (1) · Italy (1) · Mexico (1) · Netherlands (1) · Spain (1) · United States (1)
Somsook Santibenchakul, Master (2)
2008 (3), 2009 (1)